Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
Genomic Cancer Panel & Profiling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer, Others), By Application (Clinical, Research), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Others), By End-User (Hospitals, Clinical and Diagnostic Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Genomic Cancer Panel & Profiling Market is projected to expand from a valuation of USD 11.09 Billion in 2025 to USD 19.16 Billion by 2031, registering a CAGR of 9.54%. These diagnostic tech...
January 2026
180 pages
Genomic Cancer Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Others), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Genomic Cancer Testing Market is projected to expand from USD 14.48 Billion in 2025 to USD 26.37 Billion by 2031, reflecting a CAGR of 10.51%. This market consists of diagnostic solutions d...
January 2026
185 pages
Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Colorectal Cancer, Lung Cancer, Melanoma Cancer, Bladder Cancer, Others), By Technology (Immunoassays, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Immuno Oncology Assays Market is projected to expand from USD 5.47 Billion in 2025 to USD 8.21 Billion by 2031, registering a compound annual growth rate (CAGR) of 7.01%. These assays serve...
January 2026
180 pages
Sarcoma Biopsy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Product Type (Reusable Devices, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Sarcoma Biopsy Market is projected to expand from USD 300.56 Million in 2025 to USD 380.52 Million by 2031, reflecting a CAGR of 4.01%. Sarcoma biopsy serves as a critical diagnostic proces...
January 2026
180 pages
Refractory Follicular Lymphoma Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kits & Consumables), By Method (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Polymerase Chain Reaction (PCR), Others), By End User (Hospitals, Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Refractory Follicular Lymphoma Diagnostics Market is projected to expand from USD 0.49 Billion in 2025 to USD 0.69 Billion by 2031, registering a CAGR of 5.87%. This sector comprises specia...
January 2026
180 pages
Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Next Generation Cancer Diagnostics Market is projected to expand from USD 16.02 Billion in 2025 to USD 25.89 Billion by 2031, registering a CAGR of 8.33%. These advanced diagnostic systems...
January 2026
181 pages
Cancer Biopsy Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Biopsy Market is projected to expand from USD 36.73 Billion in 2025 to USD 68.59 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 10.97%. A cancer biopsy involves...
January 2026
181 pages
Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Non-Oncology), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represe...
January 2026
150 pages
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... the top manufacturers of Brachytherapy Afterloaders, Brachytherapy Seeds, with price, sales, revenue and global market share of Brachytherapy Afterloaders, Brachytherapy Seeds in 2017 and 2018. Chapter 3, the Brachytherapy Afterloaders, Brachytherapy Seeds competitive situation, sales ...
January 2026
103 pages
Global Cancer Treatment Drugs Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Cancer Treatment Drugs, with price, sales, revenue and global market share of Cancer Treatment Drugs in 2017 and 2018. Chapter 3, the Cancer Treatment Drugs competitive situation, sales, revenue and global market share ...
January 2026
155 pages
Global Breast Cancer Screening Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... display the global Breast Cancer Screening market. Chapter 1, to describe Breast Cancer Screening Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Breast Cancer Screening, with ...
January 2026
92 pages
The 2027-2032 World Outlook for Colerectal Cancers
US$ 1,195.00
This study covers the world outlook for colerectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Colorectal Cancers
US$ 1,195.00
This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
Colon Screening Market Size, Share & Trends Analysis Report By Type (Test, Product), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global colon screening market size was estimated at USD 40.41 billion in 2025 and projected to reach USD 57.65 billion by 2033, growing at a CAGR of 4.60% from 2026 to 2033. The growing prevalence...
January 2026
120 pages
Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product (Kits & Reagents, Blood Collection Tubes), By Technology, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global circulating tumor cells market size is anticipated to reach USD 17.56 billion by 2025 growing at a CAGR of 15.0% during ... in EMT study is expected to serve as an impetus for diagnosis of tumor North America led the CTC market in 2018 due to rising cases of cancer, oncology research ...
December 2025
120 pages
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Product (Platform-based, Instrument-based), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global breast cancer diagnostics market size was estimated at USD 5.86 billion in 2025, and is projected to reach USD 11.36 billion by 2033, growing at a CAGR of 8.8% from 2026 to 2033. The growt...
December 2025
130 pages
Prostate Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Preliminary Tests, Confirmatory Tests), By Type (Adenocarcinoma, Interstitial cell carcinoma, Others), By End use (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Prostate Cancer Diagnostics Market, valued at USD 8.92 Billion in 2024, is projected to experience a CAGR of 9.25% to reach USD 15.17 Billion by 2030. Prostate cancer diagnostics encompass...
December 2025
185 pages
Lung Cancer Genomic Testing Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Fluorescence In-Situ Hybridization, and Others), By Sample Type (Tissue Biopsy and Liquid Biopsy), By Panel Type (Multi-Gene Panel and Single-Gene Panel), By End-User (Research Organization, Hospitals & Clinics, Diagnostic Laboratories, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Lung Cancer Genomic Testing Medicine Market will grow from USD 1.90 Billion in 2024 to USD 2.59 Billion by 2030 at a 5.30% CAGR. Lung cancer genomic testing medicine encompasses the analysi...
December 2025
180 pages
Middle East Cancer And Tumor Marker Assays Market Size, Share & Trends Analysis Report By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer), By Biomarker Type, By End Use, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The Middle East cancer and tumor marker assays market size was estimated at USD 228.74 million in 2024 and is expected to reach USD 579.12 million by 2033, growing at a CAGR of 11.66% from 2025 to 203...
November 2025
130 pages
Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Cancer Type (Melanoma, Non-Melanoma), By Test Type (Dermatoscopy, Skin Biopsy, Lymph Node Biopsy, Imaging Tests) By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global skin cancer diagnostics market size was estimated at USD 9.58 billion in 2024 and is projected to reach USD 15.67 billion by 2033, growing at a CAGR of 5.7% from 2025 to 2033. The integrati...
October 2025
125 pages
Cancer And Tumor Biomarker-based Assay Market Size, Share & Trends Analysis Report By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer), By Biomarker Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global cancer and tumor biomarker-based assay market size was estimated at USD 10.97 billion in 2024 and is projected to reach USD 26.81 billion by 2033, growing at a CAGR of 10.50% from 2025 to 2...
October 2025
150 pages
Head And Neck Cancer Diagnostics Market Outlook 2025-2034: Market Share, and Growth Analysis By Diagnostic Method (Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods ), By Channel (Retail and Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies), By End-User
US$ 3,950.00
The Head And Neck Cancer Diagnostics Market is valued at USD 2.6 billion in 2025 and is projected to grow at a CAGR of 17.7% to reach USD 11.2 billion by 2034.The head and neck cancer diagnostics mark...
October 2025
160 pages
Ovarian Cancer Diagnostics Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Instruments, Kits, Reagents), By Diagnosis Type (Biopsy, Blood Test, Imaging, Other Diagnosis Types), By Cancer Type, By End User
US$ 3,950.00
The Ovarian Cancer Diagnostics Market is valued at USD 3.8 billion in 2025 and is projected to grow at a CAGR of 7.8% to reach USD 7.5 billion by 2034.The ovarian cancer diagnostics market is experien...
October 2025
160 pages
